Trials / NCT07656753
Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy
Recruiting now Early Phase 1 Drug / neuroprotection
- Sponsor
- Peking Union Medical College Hospital
- Treatment
- PUMCH-E111 Injection（Low dose）; PUMCH-E111 Injection（High dose）
- Gene
- RLBP1
- Conditions
- Inherited Retinal Dystrophy, Inherited Retinal Disease
- Ages
- 18 Years to 55 Years
- Enrollment
- 6 participants
- Started
- 2026-02-03
- Main results expected
- 2027-06-30
- Results posted
- Not yet
- Record last updated
- 2026-06-18
What the study is testing
The goal of this clinical trial is to evaluate the safety and efficacy of PUMCH-E111 injection in subjects with RLBP1 related Inherited Retinal Dystrophy.
Where it runs
China (1)
- Peking Union Medical College Hospital, Beijing, Beijing Municipality (recruiting now)